Introduction: Anti-cyclic citrullinated peptide (anti-CCP) antibodies have been considered very specific for rheumatoid arthritis (RA). Some studies have shown that these antibodies can be positive in infectious diseases like TB, HIV, etc.
Introduction
A nti-cyclic citrullinated peptide (anti-CCP) antibodies have been considered very specific for rheumatoid arthritis (RA). The introduction of tests recognizing anti-CCP has caused a revolution in rheumatology.
1,2 The presence of antibodies against citrullinated proteins is a feature that was c o n s i d e r e d t o b e u n i q u e f o r rheumatoid arthritis. However, r e c e n t l y a n t i -C C P a n t i b o d i e s have been detected in patients suffering from infectious diseases like tuberculosis (TB), human immunodeficiency virus (HIV), leprosy, leishmaniasis and others. Patients with HIV-TB co-infection a n d p a t i e n t s o f i n f l a m m a t o r y arthritis were excluded. Complete Japan, Israel and Brazil about anti-CCP positivity in tuberculosis. However, no data is available from India. Hence, this study was designed to corroborate the positivity of anti-CCP antibodies in tuberculosis because the prevalence of tuberculosis is very high in India. To the best of our knowledge, this is the first study from India evaluating anti-CCP antibodies in tuberculosis.
Material and Methods
T h i s w a s a p r o s p e c t i v e b l o o d c o u n t s , l i ve r a n d r e n a l function tests, serum electrolytes erythrocyte sedimentation rate were done on each patient. Chest X-rays, pleural fluid analysis, ultrasound thorax and abdomen, CT scan of brain, thorax or abdomen, MRI brain, sputum for acid fast bacilli, fundoscopy, cerebrospinal f l u i d a n a l y s i s a n d c u l t u r e o f Mycobacterium tuberculosis were done as per individual patient's requirement for the diagnosis of tuberculosis. Anti-CCP antibody was tested by 2 nd generation ELISA on each patient and results were obtained with specific titres. The titres of >14 IU/ml were considered p o s i t i v e a s s p e c i f i e d b y t h e laboratory (0-14 IU/ml negative as per the laboratory range).
Results
Fifty patients of tuberculosis were enrolled in the study; of w h i c h 3 1 w e r e d i a g n o s e d t o h a ve p u l m o n a r y T B , 1 7 we r e extra-pulmonary and two were disseminated extra-pulmonary TB. The distribution of the extrapulmonary cases is shown in Table  1 . Table 2 shows the distribution of pulmonary TB cases as regards anti-CCP antibodies. Of the 31 patients of pulmonary TB, nine were sputum positive and 22 were sputum negative. Of the nine sputum positive, five (55.56%) were positive for anti-CCP antibodies a n d f o u r we r e n e g a t i ve . O u t o f 2 2 s p u t u m n e g a t i ve , s e ve n (31.81%) were positive for anti CCP antibodies. Thus anti-CCP positivity (in percentage) was more in sputum-positive than s p u t u m -n e g a t i ve t u b e r c u l o s i s in this study. In total anti-CCP antibodies were positive in 12 cases (38.70%) of pulmonary tuberculosis and negative in nineteen (61.30%). Table 3 shows the distribution of extra-pulmonary TB cases as r e g a r d s a n t i -C C P a n t i b o d i e s . Due to a smaller sample size of individual extra-pulmonary TB cases, no concrete conclusions can be drawn. However, this is an eyeopener to conduct further research in this field.
Statistical analysis with Chi
Square test was applied using SPSS software version 16 to compare the correlation between pulmonary and extra-pulmonary cases of tuberculosis and their anti-CCP values. There was a statistical significance while comparing the pulmonary and extra-pulmonary tuberculosis cases as regards to anti-CCP antibodies (p<0.05). Table 4 enumerates the various studies of anti-CCP positivity in tuberculosis.
I n o u r s t u d y we c o m p a r e d anti-CCP antibodies in pulmonary a s w e l l a s e x t r a -p u l m o n a r y tuberculosis. Of the 31 cases of pulmonary TB, 12 (38.70%) were positive for anti-CCP antibodies. Thus our results were similar to the first two studies mentioned a b o v e . We a l s o f o u n d t h a t anti-CCP antibody was positive in two out of 19 cases of extrapulmonary TB (10.5%). In patients with TB pleural effusion (n=7), C N S t u b e r c u l o s i s ( n = 3 ) a n d osteoarticular tuberculosis (n=3) none were positive for anti-CCP antibodies. Whereas one case of abdominal TB (n=3) (33.33%) and one case of TB choroid granuloma (n=1) (100%) were positive for a n t i -C C P a n t i b o d i e s . N o n e o f the two cases of disseminated extra-pulmonary TB were positive This was an additional aspect of our study.
In this study three cases of pulmonary TB had hemoptysis of which all (i.e. 100%) were positive for anti-CCP antibodies. Also t h r e e c a s e s h a d AT T -i n d u c e d hepatitis of which two cases (i.e. 66.67%) were positive for anti-CCP antibodies. Due to these small numbers we cannot derive any significant conclusions from these three cases; however whether a n t i -C C P a n t i b o d i e s c o u l d b e predictor of hemoptysis or druginduced hepatitis in this situation is an unanswered question. A further study with a larger sample size is recommended to confirm these findings and to draw any reasonable conclusions.
The major limitation of our study was a small sample size due to financial constraints. However, after comparing the results with the earlier reported studies, our sample size and results are at par with the studies reported from Israel and Japan. It is recommended to conduct a further research in this field with a larger sample size recruiting equal number of p u l m o n a r y , e x t r a -p u l m o n a r y cases and controls in 1:1:1 ratio to reproduce our results and answer the unanswered questions in this field.
Conclusions
A n t i -C C P a n t i b o d i e s c a n be falsely positive in cases of tuberculosis. Positivity of anti-CCP antibodies for tuberculosis is more for pulmonary (more for sputum positive than sputum negative) than extra-pulmonary TB. The low prevalence of anti-CCP positivity in extrapulmonary tuberculosis could be due to decreased ability of patients to mount an inflammatory response in cases of disseminated tuberculosis and CNS tuberculosis. It is postulated that anti-CCP p o s i t i v i t y i n t u b e r c u l o s i s i s secondary to citrullinated proteins in granulomas. Anti-CCP thus is not very specific for rheumatoid arthritis. Its positivity in other diseases like TB cannot be ignored, especially in a country like India w h e r e t u b e r c u l o s i s i s h i g h l y prevalent.
